Opinions
Jim Cramer - Mad Money
Rigel Pharmaceuticals
RIGL-Q
DON'T BUY
May 07, 2021
It has a lot of inflammatory, auto-immune competition. Spec stocks in this business, he can't recommend.
$3.370
Stock price when the opinion was issued
Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising